Optimising Australia’s Medical Device Regulatory Scheme – insights and opportunities
| Wednesday, May 7, 2025 |
| 8:50 AM - 9:35 AM |
| Pyrmont Theatre |
Details
The commercialisation of any medical device requires the critical step of achieving regulatory approval. AusBiotech recently commissioned a comprehensive review of the Australian medical device regulatory landscape with a view to identifying opportunities to strengthen and optimise the regulatory process in Australia for medical device companies seeking to have their product registered. In this session you will be the first to hear the outcomes of that review and the plan for how industry and the TGA can both work toward positive improvements within our medical device regulatory landscape.
Speaker
Ms Rebekah Cassidy
Chief Executive Officer
AusBiotech Ltd
Chair
Ms Tracey Duffy
First Assistant Secretary, Medical Devices and Product Quality Division
Therapeutic Goods Administration
Speaker
Prof. John Skerritt AM
Enterprise Professor in Health Research Impact
The University of Melbourne
Speaker
